What do we know today about drug-induced microscopic colitis? A case of lymphocytic colitis on olmesartan
Acta Gastro Enterologica Belgica · 2023
DOI: 10.51821/86.3.11361 ↗Kurz gefasst
Fallbericht in der Zeitschrift Acta Gastro Enterologica Belgica, 2023. Verfasst von A Djembissi Fotso und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Centre Hospitalier Régional de la Haute Senne, Soignies, Belgium. Hauptthemen laut MEDLINE: Colitis, Collagenous, Colitis, Lymphocytic, Colitis, Microscopic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Microscopic colitis is part of the differential diagnosis of chronic watery diarrhea. Colonoscopy discloses a normal looking mucosa, therefore its diagnosis is based on histology of colonic biopsies. Two main phenotypes are distinguished: collagenous colitis and lymphocytic colitis. A third entity, incomplete microscopic colitis or unspecified microscopic colitis has been reported in the literature. It affects preferentially women over 60 years of age and its association with certain drugs is increasingly established. In case of suspected drug-induced microscopic colitis, identification of the responsible drug is a key to management. After discontinuation of the suspected drug, the gold standard of treatment is budesonide both for induction and for maintenance in case of clinical relapse, as is often the case after discontinuation. Therapy with immunomodulators, biologics, or surgery is reserved for refractory forms of microscopic colitis after multidisciplinary consultation. Through the clinical case of colitis on olmesartan, we will review the latest recommendations on drug-induced microscopic colitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Centre Hospitalier Régional de la Haute Senne, Soignies, Belgium.
- Department of Gastroenterology, Erasme Hospital, Université Libres de Bruxelles (ULB), Brussels, Belgium.
Zitieren
APA
Djembissi Fotso, A., Arvanitakis, M., Salame, M., Gallez, J., & Lakis, A. (2023). What do we know today about drug-induced microscopic colitis? A case of lymphocytic colitis on olmesartan. Acta Gastro Enterologica Belgica. https://doi.org/10.51821/86.3.11361
Vancouver
Djembissi Fotso A, Arvanitakis M, Salame M, Gallez J, Lakis A. What do we know today about drug-induced microscopic colitis? A case of lymphocytic colitis on olmesartan. Acta Gastro Enterologica Belgica. 2023. doi:10.51821/86.3.11361
BibTeX
@article{DjembissiFotso2023,
author = {Djembissi Fotso, A and Arvanitakis, M and Salame, M and Gallez, J and Lakis, A},
title = {What do we know today about drug-induced microscopic colitis? A case of lymphocytic colitis on olmesartan},
journal = {Acta Gastro Enterologica Belgica},
year = {2023},
doi = {10.51821/86.3.11361}
}
EUVIMED